Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Cancer Treatment
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The study will be non randomized, open label, dose rising study in cancer patients. Cancer
treatment is consisting of 2 different drugs: Oshadi D and Oshadi R that will be administered
orally.
The study will include two sessions:
- A single dose period to evaluate acute toxicity of each drug
- Consecutive multiple increment dose escalation period of both drugs to determine the
long-term safety, and the anticancer activity.